Replies to post #39379 on Pluristem Therapeutics Inc (PSTI)

[jaime9_2000]

Thanks, Midas. Today's news is a relief. Given that PSTI is headquartered in Israel, I couldn't understand why the Israeli government had not been a participant in our trials. It made me wonder if they knew something bad about PSTI or our products. I am glad to see that they are on board. Today's news might also be another piece in the puzzle. It might explain why PSTI had not yet begun enrollment in the 40 person trial approved by Germany a few months ago.

OK, PSTI, good job. Now let's get moving on these trials!

[zzaatt]

I think it's very encouraging to see Pluristem proceed with the clinical work. It does seem to indicated that they've seen nothing to discourage them from proceeding. This is good, given the doubt created by the very slow progress in Covid testing.

It's also interesting to speculate that even as other therapeutics are coming on line, the PLX cell's more natural and specific "as needed" response may be superior in the long run. "Titrate to need" on a cellular and molecular level is something that monocloal antibodies cannot do.